Analysts forecast that Stericycle Inc (NASDAQ:SRCL) will post $849.97 million in sales for the current fiscal quarter, according to Zacks Investment Research. Eight analysts have issued estimates for Stericycle’s earnings, with the highest sales estimate coming in at $866.30 million and the lowest estimate coming in at $834.50 million. Stericycle posted sales of $883.30 million during the same quarter last year, which suggests a negative year-over-year growth rate of 3.8%. The company is scheduled to announce its next earnings results on Thursday, August 1st.
According to Zacks, analysts expect that Stericycle will report full-year sales of $3.41 billion for the current financial year, with estimates ranging from $3.38 billion to $3.46 billion. For the next year, analysts expect that the firm will post sales of $3.50 billion, with estimates ranging from $3.45 billion to $3.58 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that follow Stericycle.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings data on Thursday, February 28th. The business services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.07. The business had revenue of $852.70 million for the quarter, compared to analyst estimates of $848.75 million. Stericycle had a positive return on equity of 12.56% and a negative net margin of 8.92%.
Several analysts recently weighed in on SRCL shares. BidaskClub raised Stericycle from a “strong sell” rating to a “sell” rating in a research note on Thursday, January 24th. Zacks Investment Research lowered Stericycle from a “hold” rating to a “sell” rating in a research note on Friday, February 15th. Goldman Sachs Group raised Stericycle from a “neutral” rating to a “buy” rating and set a $66.00 price objective on the stock in a research note on Friday, March 1st. BMO Capital Markets raised their price objective on Stericycle from $41.00 to $45.00 and gave the company a “market perform” rating in a research note on Monday, March 4th. Finally, ValuEngine raised Stericycle from a “strong sell” rating to a “sell” rating in a research note on Tuesday, March 5th. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and three have assigned a buy rating to the stock. Stericycle has a consensus rating of “Hold” and a consensus target price of $59.00.
In other news, Director Mark C. Miller sold 260,314 shares of Stericycle stock in a transaction dated Tuesday, April 9th. The stock was sold at an average price of $57.18, for a total transaction of $14,884,754.52. Following the sale, the director now directly owns 325,848 shares of the company’s stock, valued at $18,631,988.64. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 2.30% of the company’s stock.
Hedge funds have recently made changes to their positions in the company. Vanguard Group Inc raised its position in shares of Stericycle by 2.6% during the third quarter. Vanguard Group Inc now owns 9,015,988 shares of the business services provider’s stock worth $529,058,000 after acquiring an additional 228,533 shares during the last quarter. BlackRock Inc. raised its position in shares of Stericycle by 40.9% during the fourth quarter. BlackRock Inc. now owns 7,616,828 shares of the business services provider’s stock worth $279,461,000 after acquiring an additional 2,210,880 shares during the last quarter. Clarkston Capital Partners LLC raised its position in shares of Stericycle by 2.7% during the first quarter. Clarkston Capital Partners LLC now owns 4,106,285 shares of the business services provider’s stock worth $223,464,000 after acquiring an additional 107,400 shares during the last quarter. Iridian Asset Management LLC CT bought a new position in shares of Stericycle during the first quarter worth about $168,624,000. Finally, Oregon Public Employees Retirement Fund raised its position in shares of Stericycle by 6,998.9% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,638,209 shares of the business services provider’s stock worth $45,000 after acquiring an additional 1,615,132 shares during the last quarter. 96.52% of the stock is currently owned by hedge funds and other institutional investors.
NASDAQ:SRCL opened at $48.79 on Thursday. The stock has a market capitalization of $4.45 billion, a P/E ratio of 10.96, a price-to-earnings-growth ratio of 1.90 and a beta of 1.11. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 1.17. Stericycle has a twelve month low of $34.36 and a twelve month high of $71.43.
Stericycle, Inc, together with its subsidiaries, provides regulated and compliance solutions to the healthcare, retail, and commercial businesses in the United States and internationally. It operates through three segments: Domestic and Canada Regulated Waste and Compliance; International Regulated Waste and Compliance; and Domestic Communication and Related Services.
Further Reading: Why is the ROA ratio important?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Stericycle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle and related companies with MarketBeat.com's FREE daily email newsletter.